Funded Tech Companies

CorriXR Therapeutics

CorriXR Therapeutics is a biopharmaceutical growth company, based in Newark. Venture investment and financing came from private investors.

Company Overview

Company Name
CorriXR Therapeutics
Company Status
Private & Independent
Funding Rounds
Total Funding

Contact Information

Mailing Address
550 S. College Avenue 107
Newark, DE 19713
USA
Phone
Undisclosed
Email Address

Company Background Information

Overview
CorriXR Therapeutics is an oncology-focused biotherapeutics development company enabled by a novel IP-protected in vivo gene editing therapeutic platform technology. We advance the science of gene editing by capitalizing on cutting-edge platform technology, having a strong team, and showcasing the ability to build ventures that address key areas with significant therapeutic gaps. Our team emphasizes equity, bringing our latest discoveries to diverse communities who are often excluded from clinical trials and treatments.
Profile
CorriXR Therapeutics LinkedIn Company Profile
Social Media
CorriXR Therapeutics Company Twitter Account
Company News
CorriXR Therapeutics News
Facebook
CorriXR Therapeutics on Facebook
YouTube
CorriXR Therapeutics on YouTube
Last Transaction
8/19/2025

Financing History

Date
Type
Amount
Venture Equity
$1,000,000


Management Team

Title
Name
Email & Social
Chief Executive Officer
Eric Kmiec
  Eric Kmiec LinkedIn Profile  Eric Kmiec Twitter Account  Eric Kmiec News  Eric Kmiec on Facebook


Company Investors

     

     

     

    Browse more funded tech companies:

    Corrigo | CorrosionRADAR

     

    Share this article

     


    About Our VC Transaction Database

    Our data comes from VentureDeal.com, a market leader in private equity transaction data.

     


    Additional Resources for Entrepreneurs

    Lists of Venture Capital and Private Equity Firms

    Franchise Opportunities

    Contributors

    Business Glossary